BCL2 and diabetic kidney disease: In a diabetic nephropathy model, the administration of mitochondria effectively abolished ROS production by restoring the levels of superoxide dismutase 2 (SOD2) and preventing apoptosis through the upregulation of Bcl-2 protein.